Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Grant of Share Options - replacement

March 1, 2024
RNS Number : 3507F Renalytix PLC 01 March 2024   The following amendment has been made to the ' Grant of Share Options ' announcement released on 23 November 2023 at 07:00 under RNS No 3917U .   The sentence " All the Share Options granted one twelfth of the Share Options vest 3 months from the

US Government coverage expanded

February 29, 2024
RNS Number : 9346E Renalytix PLC 29 February 2024     THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF MAR. THE PERSON RESPONSIBLE FOR ARRANGING THE RELEASE OF THIS ANNOUNCEMENT ON BEHALF OF RENALYTIX IS JAMES MCCULLOUGH , CEO.   Renalytix plc ("Renalytix" or the "Company")

Half Year Report

February 15, 2024
RNS Number : 2070D Renalytix PLC 15 February 2024   Renalytix plc ("Renalytix" or the "Company")   Half Year Report   LONDON and SALT LAKE CITY , February 15, 2024   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing

Renalytix to Participate in the BTIG Conference

February 9, 2024
RNS Number : 6963C Renalytix PLC 09 February 2024     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Participate in the BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference   LONDON and SALT LAKE CITY , February 9, 2024 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX)

CMS publishes Draft Local Coverage Determination

February 9, 2024
RNS Number : 5654C Renalytix PLC 09 February 2024     Renalytix plc ("Renalytix" or the "Company")   Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd   LONDON and SALT LAKE CITY , February 9, 2024 - Renalytix plc (NASDAQ:

Update on kidneyIntelX.dkd LCD Consideration

January 17, 2024
RNS Number : 9171Z Renalytix PLC 17 January 2024     Renalytix plc ("Renalytix" or the "Company")   Update on kidneyIntelX.dkd Local Coverage Determination Consideration   Local Coverage Determination would result in   contracted coverage for an estimated additional five million Medicare patients  

New published data for KidneyIntelX™

January 10, 2024
RNS Number : 1665Z Renalytix PLC 10 January 2024     Renalytix plc ("Renalytix" or the "Company")   New published data for   KidneyIntelX™   New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease   Electronic health record deployment of

Issue of Shares

December 18, 2023
RNS Number : 0685X Renalytix PLC 18 December 2023   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares   LONDON and SALT LAKE CITY -   December 18, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of the Company's convertible bond and the

Result of AGM

December 15, 2023
RNS Number : 0572X Renalytix PLC 15 December 2023   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 15 December 2023   - Renalytix (NASDAQ: RNLX)  (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical

Directorate Change

December 8, 2023
RNS Number : 2472W Renalytix PLC 08 December 2023   Renalytix plc ("Renalytix" or the "Company")   Directorate Change   LONDON and SALT LAKE CITY -   December 8, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX),   an artificial intelligence-enabled in vitro diagnostics company, focused on
Displaying 1 - 10 of 285